RTP Mobile Logo

Current Controversies, Recent Developments and Emerging Strategies in the Practical Management of Non-Small Cell Lung Cancer

SABCS14

TARGET AUDIENCE
This activity is intended for medical oncologists, breast cancer surgeons and other healthcare providers involved in the treatment of breast cancer.

OVERVIEW OF ACTIVITY
Breast cancer remains the most frequently diagnosed cancer in women, and in 2013 in the United States alone the disease culminated in an estimated 232,340 new cases and 39,620 estimated deaths. Advances in screening and prevention have resulted in a steady down-stage migration at the time of disease presentation, such that only 5% of women have identifiable distant metastases at primary diagnosis. Because of this, the number of individuals living with breast cancer has increased substantially, as has the population “at risk” for recurrent disease.

The New Biology of NSCLC

Keynote Lecture - Personalized Therapy in Lung Cancer: Ready for Prime Time?

LCUTT114/Video

TARGET AUDIENCE
This activity has been designed to meet the educational needs of medical oncologists, hematologist-oncologists, radiation oncologists, fellows and other healthcare providers involved in the treatment of lung cancer.

LCUTT114/Audio

OVERVIEW OF ACTIVITY

ASHNHL16

TARGET AUDIENCE
This activity is intended for hematologists, medical oncologists, hematology-oncology fellows and other healthcare providers involved in the treatment of hematologic cancers.

OVERVIEW OF ACTIVITY

Consensus or Controversy? Investigator Perspectives on Practical Issues and Research Questions in Non-Hodgkin Lymphoma

Consensus or Controversy?

Consensus or Controversy? Investigator Perspectives on Practical Issues and Research Questions in Multiple Myeloma

Consensus or Controversy?

ASHMM14

TARGET AUDIENCE
This activity is intended for hematologists, medical oncologists, hematology-oncology fellows and other healthcare providers involved in the treatment of multiple myeloma (MM).

OVERVIEW OF ACTIVITY

Targeted Therapeutic Options in Non-Hodgkin Lymphomas

RELEVANCE Trial Design

Targeted Therapeutic Options in Non-Hodgkin Lymphomas

ECOG-E2408 Trial Design


Oncology Nursing Update Lung Cancer Edition, Issue 1, 2014

OVERVIEW OF ACTIVITY

CNS Tumor Panel and Journal Club: Clinical Investigators Provide Perspectives on Current Cases and Key Presentations and Publications

CNS Tumor Panel and Journal Club:

5MJCASH2014

OVERVIEW OF ACTIVITY

Each year, thousands of clinicians, basic scientists and other industry professionals sojourn to major international oncology conferences, like the American Society of Hematology (ASH) annual meeting, to hone their skills, network with colleagues and learn about recent advances altering state-of-the-art management in hematologic oncology. As such, these events have become global stages where exciting science, cutting-edge concepts and practice-changing data emerge on a truly grand scale. This massive outpouring of information has enormous benefits for the hematologic oncology community, but the truth is it also creates a major challenge for practicing oncologists and hematologists.